Status:
COMPLETED
Risperidone for the Treatment of Cocaine Dependence - 7
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
21-50 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate clinical safety and pharmacological efficacy in the treatment of cocaine dependence, to evaluate impact of treatment on craving, and to correlate evidence of b...
Eligibility Criteria
Inclusion Criteria:
M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent.
Exclusion Criteria:
Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.
Key Trial Info
Start Date :
July 1 1996
Trial Type :
INTERVENTIONAL
End Date :
September 1 1997
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000342
Start Date
July 1 1996
End Date
September 1 1997
Last Update
January 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Friends Research Institute
Los Angeles, California, United States, 90025